Macular Carotenoids and AMD Conference

8th - 10th July 2015

Downing College, Cambridge University, UK



Recognition for work in improving vision for patients with age-related macular degeneration (the leading cause of blindness in the western world)

A WIT academic has been recognised for his contribution to medicine at a prestigious awards ceremony in New York.

WIT’s Professor John Nolan, Principal Investigator of the Macular Pigment Research Group (MPRG) made the 2015 Irish America Healthcare and Life Sciences 50 list.

On 7 October, Irish America magazine celebrated the Healthcare/Life Sciences 50 honorees at a reception in New York City.

The Irish America Healthcare and Life Sciences 50 recognizes the work of Irish-American and Irish-born medical professionals who are contributing everyday to the health and wellness of our communities, from pharmaceuticals, medical devices and biotechnology to research and development and medical care. The Healthcare / Life Sciences 50 are featured in the August/September edition of Irish America.

“Our annual Health Care & Life Sciences 50 honors Irish and Irish-American innovators who are leading the way in diagnosis, treatment, and prevention of disease, and in this context, we are delighted to highlight the extraordinary work of Professor John Nolan. We applaud his excellent research into the cause of Age Related Macular Degeneration, which has brought new hope to the millions worldwide affected by the disease. And we are excited to follow his latest efforts into halting the onset of Alzheimer’s and improve cognitive function in those who have the disease. Prof Nolan’s work has put WIT on the map and we couldn’t be more proud,” said Patricia Harty, Co-Founder and Editor in Chief of Irish America.

“Professor Nolan’s work is making a significant impact in the field of vision research and latterly dementia. As such his work plays a significant part in the promotion of WIT as a seat of learning and centre for cutting edge research on both the national and international stage. His award as an honoree of the Irish America Healthcare and Life Sciences 50 list is highly prestigious and is not only a recognition of the quality of the research contribution made by Professor Nolan and the research team he leads to his field of expertise but brings great honour to the entire research community in the School of Health Science and the wider academic community within WIT,” said Professor John Wells, Head of the School of Health Science, WIT.

Prof Nolan said it is a great honour for him and his family to be recognised in this way.

“For me, this award reflects the efforts of all my team who continue to work tirelessly in our important research field. Our work has already contributed greatly to science and medicine, and it is amazing that the nutrients that we have been studying and identifying are now used worldwide for human health, in particular to improve vision for patients with age-related macular degeneration (the leading cause of blindness in the western world),” he said.

“Our recent work using nutrition for Alzheimer’s disease and cognitive function represents exciting potential for the future. It is wonderful that we have been able to achieve this work in Waterford, Ireland, at the Waterford Institute of Technology, and that our multi-disciplinary team have access to cutting edge specialised technology, which empowers them conduct research at the highest level,” he continued.

“I am also most grateful to our research sponsors, the European Research Council, and the Howard Foundation, UK, for their continued support of our work, without which awards such the Irish America, Healthcare and Life Sciences 50 – 2015 would not be possible.”

Conference Sponsors

Headline Sponsors

MacuHealth is a Michigan Base company focused on preserving vision health and vision performance by providing the only scientifically designed, tested and proven formulations with all three carotenoids found in the eye, (Lutein, Zeaxanthin and Meso-Zeaxanthin). Our sharp focus and commitment to “Trust The Science” is driven by our desire to help improving and preserving vision as well as preventing and managing Age-Related Macular Degeneration, the leading cause of vision loss in North America. Our products are distributed in Europe by MacuVision Europe under the brand MacuShield and in the rest of the world as MacuHealth with LMZ3™ (AMD, Night Vision and Glare) and ClearVision.PRO™ (for athletes, casual and professional and outdoors persons).

Industrial Orgánica (IOSA) is a worldwide company established since 1966, and is currently one of the leaders in providing the macular carotenoids from natural sources. IOSA are committed to research and innovation with the aim to produce compounds to promote health and wellbeing. IOSA are proud to be participating at the Macular Carotenoids 2015 research conference as the Headline Sponsor.

The third international Conference solely dedicated to the macular carotenoids - lutein, zeaxanthin and meso-zeaxanthin